Patients with a cardiac complete response in AL amyloidosis have survival rates similar to those of a matched general population

2.

Dispenzieri

A

,

Gertz

MA

,

Kyle

RA

, et al.

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

.

J Clin Oncol

.

2004

;

22

(

18

):

3751

-

3757

.

3.

Muchtar

E

,

Dispenzieri

A

,

Gertz

MA

, et al.

Treatment of AL amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement 2020 update

.

Mayo Clin Proc

.

2021

;

96

(

6

):

1546

-

1577

.

4.

Gertz

MA

,

Cohen

AD

,

Comenzo

RL

, et al.

Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial

.

Blood

.

2023

;

142

(

14

):

1208

-

1218

.

5.

Palladini

G

,

Dispenzieri

A

,

Gertz

MA

, et al.

New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes

.

J Clin Oncol

.

2012

;

30

(

36

):

4541

-

4549

.

6.

Kaufman

GP

,

Dispenzieri

A

,

Gertz

MA

, et al.

Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis

.

Am J Hematol

.

2015

;

90

(

3

):

181

-

186

.

7.

Manwani

R

,

Cohen

O

,

Sharpley

F

, et al.

A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib

.

Blood

.

2019

;

134

(

25

):

2271

-

2280

.

8.

Milani

P

,

Basset

M

,

Nuvolone

M

, et al.

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy

.

Blood Cancer J

.

2020

;

10

(

8

):

90

.

9.

Muchtar

E

,

Dispenzieri

A

,

Leung

N

, et al.

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

.

Leukemia

.

2018

;

32

(

10

):

2240

-

2249

.

10.

Lilleness

B

,

Ruberg

FL

,

Mussinelli

R

,

Doros

G

,

Sanchorawala

V

.

Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis

.

Blood

.

2019

;

133

(

3

):

215

-

223

.

11.

Muchtar

E

,

Dispenzieri

A

,

Wisniowski

B

, et al.

Graded cardiac response criteria for patients with systemic light chain amyloidosis

.

J Clin Oncol

.

2023

;

41

(

7

):

1393

-

1403

.

12.

Perme

MP

,

Pavlic

K

.

Nonparametric relative survival analysis with the R package relsurv

.

J Stat Softw

.

2018

;

87

(

8

):

1

-

27

.

13.

Therneau

TM

,

Lumley

T

,

Atkinson

E

,

Crowson

C

.

A package for survival analysis in R. R package version 3.5-7

. 2023. Accessed 28 April 2024. https://CRAN.R-project.org/package=survival.

14.

Team RC R: A language and environment for statistical computing URL

. R Foundation for Statistical Computing.

2021

Accessed 28 April 2024. https://www.R-project.org/.

15.

Muchtar

E

,

Wisniowski

B

,

Palladini

G

, et al.

Graded renal response criteria for light chain (AL) amyloidosis [abstract]

.

Blood

.

2021

;

138

(

suppl 1

):

2721

.